Federico II university
Naples, 80131, Italy
NCT Number: NCT06247709
OBJECTIVE: The objective of this study is to evaluate the correlation between KLHL14 expression and its cytoplasm-nuclear localisation and pituitary adenomas biological behaviour with particular focus on its role in epithelial mesenchymal transition and invasion of para and suprasellar regions.
This is a multicenter and multidisciplinary study, with the involvement of the Departments of Neurosurgery of the University of Naples Federico II and the Department of Biosciences of the University of Teramo.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Naples, 80131, Italy
The investigators would like to analyse the possible correlations between the expression, the cytoplasm-nuclear localisation and the activity of the protein KLHL14 and pituitary adenomas biological behaviour with particular focus on its role in epithelial mesenchymal transition and invasion of para and suprasellar regions. This study will be conducted on biological sample collected during surgery and primary cellular line derived from those samples.
Patients refer to neurosurgery for the detection of pituitary adenomas with various presenting symptoms that can be correlated to hormone production or to mass effect produced by the lesion on the optic apparatus or on the oculomotor nerves after invasion of the cavernous sinus. All patients undergo an ophthalmological clinical examination to define the presence of visual alteration and endocrinological assessment to determine eventual hormone hypersecretion. Finally, radiological exams, as magnetic resonance of the sellar region, are performed on patients to evaluate the extension of the pathology, its relationship to the surrounding neurovascular structures and therefore guide neurosurgical resection which is typically performed via an endoscopic endonasal transsphenoidal approach. Except for prolactin secreting pituitary adenomas, for which medical therapy with dopaminergic agonists is a viable approach, surgery with adenoma resection represent the gold standard for treatment.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Lab essay evaluating the expression of KLHL 14
Time frame: Invasiveness degree will be determined at the time of surgery
The expression of KLHL14 in invasive pituitary adenomas
Federico II University
Other
Evaluation of KLHL14 Expression as a Prognostic Factor of PitNET Invasiveness
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05589207
Adenocarcinoma, Carcinoma
Beijing, Beijing Municipality, China
View Trial DetailsNCT06076135
Immune Checkpoint Blockade, Metastatic Malignant Solid Neoplasm
Shantou, Guangdong, China
View Trial DetailsNCT05282901
Eye Diseases, Eye Neoplasms
Paris, France
View Trial DetailsNCT06087770
Locally Advanced or Metastatic Solid Tumors, Neoplasm Metastasis
Guangzhou, Guangdong, China
View Trial Details